Dapagliflozin produced sustained reductions in weight and systolic blood pressure , whereas glipizide increased weight and systolic blood pressure , giving @-week dapagliflozin versus glipizide differences of -@ kg ( @ % CI : -@ , -@ ) and -@ mmHg ( @ % CI : -@ , -@ ) , respectively .